Breaking News Instant updates and real-time market news.

HAE

Haemonetics

$94.07

0.74 (0.79%)

06:15
05/07/19
05/07
06:15
05/07/19
06:15

Haemonetics reports Q4 adj. EPS 61c, consensus 55c

Reports Q4 revenue $249.3M, consensus $250.63M. Chris Simon, Haemonetics' CEO, said: "We are pleased with our strong finish to Fiscal 2019. We launched NexSys, the platform we believe is best positioned to support plasma industry growth. We also continued to reduce complexity and costs to meaningfully expand our profit margins, while freeing up resources to invest in growth. Our positive results are evidence that our strategy is sound and creating momentum for additional revenue and profitability growth in Fiscal 2020 as we drive our corporate-wide transformation."

  • 07

    May

HAE Haemonetics
$94.07

0.74 (0.79%)

02/05/19
JEFF
02/05/19
NO CHANGE
JEFF
Buy
Haemonetics weakness a buying opportunity, says Jefferies
02/06/19
JEFF
02/06/19
NO CHANGE
Target $125
JEFF
Buy
Jefferies cuts Haemonetics target, says NexSys thesis 'fully intact'
Jefferies analyst Anthony Petrone lowered his price target for Haemonetics to $125 from $135 and keeps a Buy rating on the name. The analyst says he learned more on the "three pain points" that triggered yesterday's post-earnings selloff. On Plasma, he confirmed 8%-10% is a long-term forecast but that near-term volumes and NexSys support teens growth for fiscal 2020. NexSys contract discussions are evolving with the company better positioned with real-world evidence, Petrone tells investors in a research note. The analyst pushed his numbers out but still sees a path to $5-plus in earnings per share "conservatively" through the NexSys cycle.
02/06/19
BRRR
02/06/19
NO CHANGE
Target $112
BRRR
Outperform
Haemonetics price target lowered to $112 from $127 at Barrington
Barrington analyst Michael Petusky lowered his price target for Haemonetics to $112 and keeps an Outperform rating on the shares following yesterday's Q3 results. While the plasma business "solidly exceeded" top-line expectations, the company's hospital businesses as well as the blood center business all fell a bit short, Petusky tells investors in a post-earnings research note. Further, while the conversion to the company's next generation plasma collection device continues to have positive momentum, management commentary on the conference call appeared to communicate "meaningful uncertainty" regarding near-term pacing of conversion contracting, adds the analyst. Petusky sees increased NexSys conversion pacing uncertainty but continues to "fully believe" in the long-term constructive investment thesis for Haemonetics.
05/01/19
JEFF
05/01/19
NO CHANGE
Target $125
JEFF
Buy
Haemonetics added to Franchise Picks list at Jefferies
Jefferies analyst Anthony Petrone added Haemonetics to his firm's Franchise Picks list citing the recent pullback in the shares and his view that the company is still well positioned to see "substantial" earnings upside as the NexSys cycle plays out. He believes a stock price of $150-plus is likely over time and keeps a Buy rating on Haemonetics with a $125 price target.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$230.70

1.49 (0.65%)

16:24
05/20/19
05/20
16:24
05/20/19
16:24
Initiation
Biogen initiated  »

Biogen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

SWI

SolarWinds

$19.16

0.04 (0.21%)

16:23
05/20/19
05/20
16:23
05/20/19
16:23
Syndicate
SolarWinds files to sell 17.25M shares of common stock »

JPMorgan, Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

AMGN

Amgen

$168.36

-1.5 (-0.88%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Initiation
Amgen initiated  »

Amgen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

GM

General Motors

$36.98

-0.02 (-0.05%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Periodicals
GM plans wind-down of Maven car-sharing service in some cities, WSJ says »

According to the Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

  • 05

    Jun

  • 01

    Aug

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

, AIMT

Aimmune

$19.68

-0.41 (-2.04%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Initiation
DBV Technologies, Aimmune initiated  »

Aimmune assumed with an…

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

AIMT

Aimmune

$19.68

-0.41 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Sep

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVNA

Carvana

$67.17

-0.935 (-1.37%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Syndicate
Carvana files to sell 3.5M shares of Class A common stock »

Wells Fargo Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

INCY

Incyte

$76.83

-0.41 (-0.53%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Initiation
Incyte initiated  »

Incyte initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 24

    May

  • 31

    May

  • 05

    Jun

  • 13

    Jun

GOOG

Alphabet

$1,138.33

-23.56 (-2.03%)

, GOOGL

Alphabet Class A

$1,145.28

-23 (-1.97%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks have started the…

GOOG

Alphabet

$1,138.33

-23.56 (-2.03%)

GOOGL

Alphabet Class A

$1,145.28

-23 (-1.97%)

INTC

Intel

$43.58

-1.3 (-2.90%)

QCOM

Qualcomm

$76.61

-4.91 (-6.02%)

XLNX

Xilinx

$101.05

-3.71 (-3.54%)

AVGO

Broadcom

$272.59

-17.27 (-5.96%)

S

Sprint

$7.34

1.165 (18.87%)

TMUS

T-Mobile

$78.32

2.93 (3.89%)

F

Ford

$10.28

-0.01 (-0.10%)

FB

Facebook

$182.71

-2.56 (-1.38%)

QGEN

Qiagen

$38.05

0.96 (2.59%)

MDCO

The Medicines Co.

$34.25

1.24 (3.76%)

DISH

Dish

$33.24

-2.095 (-5.93%)

SATS

EchoStar

$41.97

1.55 (3.83%)

PDD

Pinduoduo

$20.78

-1.91 (-8.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 22

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 24

    Jul

  • 25

    Jul

  • 31

    Jul

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

GH

Guardant Health

$78.29

2.13 (2.80%)

16:18
05/20/19
05/20
16:18
05/20/19
16:18
Syndicate
Guardant Health files to sell 4.5M shares of common stock »

JPMorgan and BofA/Merrill…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 05

    Jun

  • 12

    Jun

  • 18

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/20/19
05/20
16:17
05/20/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$28.08

-1.08 (-3.70%)

16:16
05/20/19
05/20
16:16
05/20/19
16:16
Syndicate
Insmed files to sell $250M of common stock »

Morgan Stanley & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/20/19
05/20
16:16
05/20/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEO

NeoGenomics

$23.19

0.22 (0.96%)

16:15
05/20/19
05/20
16:15
05/20/19
16:15
Syndicate
Breaking Syndicate news story on NeoGenomics »

NeoGenomics files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

  • 06

    Jun

  • 13

    Nov

BKNG

Booking Holdings

$1,751.62

-35.11 (-1.97%)

16:15
05/20/19
05/20
16:15
05/20/19
16:15
Initiation
Booking Holdings initiated  »

Booking Holdings assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TRIP

TripAdvisor

$45.01

0.01 (0.02%)

16:13
05/20/19
05/20
16:13
05/20/19
16:13
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 11

    Jun

EXPE

Expedia

$116.48

0.22 (0.19%)

16:13
05/20/19
05/20
16:13
05/20/19
16:13
Initiation
Expedia initiated  »

Expedia assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

MGM

MGM Resorts

$25.34

-0.54 (-2.09%)

16:11
05/20/19
05/20
16:11
05/20/19
16:11
Conference/Events
MGM Resorts participates in a conference call with UBS »

Leisure, Gaming &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 29

    May

KR

Kroger

$24.06

-0.165 (-0.68%)

16:10
05/20/19
05/20
16:10
05/20/19
16:10
Upgrade
Kroger rating change  »

Kroger upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CLVS

Clovis

$16.35

-0.68 (-3.99%)

16:08
05/20/19
05/20
16:08
05/20/19
16:08
Hot Stocks
Clovis says Rubraca increased symptom-free period in ovarian cancer patients »

Clovis Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 06

    Jun

VRSK

Verisk Analytics

$141.45

-0.56 (-0.39%)

16:07
05/20/19
05/20
16:07
05/20/19
16:07
Conference/Events
Verisk Analytics management to meet with Cantor Fitzgerald »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 05

    Jun

MRVL

Marvell

$21.73

-0.885 (-3.91%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Hot Stocks
Marvell to acquire Avera Semiconductor for $650M in cash »

Marvell announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

VNE

Veoneer

$18.84

-0.03 (-0.16%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Syndicate
Breaking Syndicate news story on Veoneer »

Veoneer files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

OCUL

Ocular Therapeutix

$3.35

-0.11 (-3.18%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Hot Stocks
Ocular Therapeutix says OTX-TP failed to meet primary endpoint in Phase 3 trial »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 10

    Nov

CBAY

CymaBay

$12.37

-0.24 (-1.90%)

16:05
05/20/19
05/20
16:05
05/20/19
16:05
Hot Stocks
CymaBay announces results related to seladelpar clinical development program »

CymaBay Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.